Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative.


Creative Commons License

Hughes D. A., Aguiar P., Deegan P. B., Ezgu F. S., Frustaci A., Lidove O., ...Daha Fazla

BMJ open, cilt.10, sa.10, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 10
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1136/bmjopen-2019-035182
  • Dergi Adı: BMJ open
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Anahtar Kelimeler: genetics, cardiomyopathy, chronic renal failure, stroke medicine, ENZYME REPLACEMENT THERAPY, UNCERTAIN DIAGNOSIS, AGALSIDASE BETA, FEMALE-PATIENTS, CHILDREN, BIOMARKER
  • Gazi Üniversitesi Adresli: Evet

Özet

Objectives The PRoposing Early Disease Indicators for Clinical Tracking in Fabry Disease (PREDICT-FD) initiative aimed to reach consensus among a panel of global experts on early indicators of disease progression that may justify FD-specific treatment initiation.